[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[ATAI Life Sciences](/topic/atai-life)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:atai-life/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/atai-life/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% no change  
**1 Month**: XX% +9%  
**6 Months**: XX% +13%  
**1 Year**: XX% +8%  
**1-Year High**: XXX% on 2024-08-25  
**1-Year Low**: XX% on 2025-03-11  

**Most Supportive Themes**
- **Positive Clinical Data:** (50%) ATAI is experiencing positive results from clinical trials and FDA designations, which is the most mentioned theme, with thousands of engagements and many posts.
- **Government Support for Psychedelics:** (35%) News of a Trump administration official joining RFK Jr.'s HHS to lead psychedelics policy and increased government support for psychedelics resulted in many mentions and engagements.
- **Increased Community Engagement:** (15%) The ATAI community shows stronger vibes with discussions around strategic partnerships and potential mergers and acquisitions, which is one of the most engaging topics, even if less mentioned.
  
**Most Critical Themes**
- **Concerns over Competitors:** (0.5%)  Concerns over competitors in the psychedelic medicine space were only mentioned a few times compared to the thousands of positive mentions.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |
| Reddit  | X        | X%  | XX      | X%  | X        | X% |
| YouTube | XX       | X%  | XX      | X%  | X        | X% |
| News    | XX       | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |